Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ondrej Suchanek

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
HLA|October 6, 2020
Novel strategies to target the humoral alloimmune responseOndrej Suchanek, Menna R Clatworthy
Frontiers in Immunology|September 25, 2023
Homeostatic role of B-1 cells in tissue immunityOndrej Suchanek, Menna R Clatworthy
Rheumatology (Oxford, England)|June 17, 2021
Therapeutic dilemmas in relapsing renal ANCA-associated vasculitisOndrej Suchanek, David R W Jayne, Rachel B Jones
CEN Case Reports|June 21, 2022
Use of rituximab in SARS-CoV-2-positive renal transplant recipient with EBV reactivation and probable haemophagocytic lymphohistiocytosisDerek Chan, Sabina Karimi, George Follows, et al.
Annual Review of Immunology|April 26, 2022
Tissue Immunity in the BladderGeorgina S Bowyer, Kevin W Loudon, Ondrej Suchanek, et al.
BMJ Quality Improvement Reports|January 7, 2016
Mind the gap: Improving discharge communication between secondary and primary careAynsley Cresswell, Matthew Hart, Ondrej Suchanek, et al.
Kidney International Reports|May 2, 2022
Incidence, Risk Factors and Outcomes of Kidney and Liver Cyst Infection in Kidney Transplant Recipient With ADPKDCharles Ronsin, Anis Chaba, Ondrej Suchanek, et al.
Frontiers in Immunology|August 1, 2024
FlowAtlas: an interactive tool for high-dimensional immunophenotyping analysis bridging FlowJo with computational tools in JuliaValerie Coppard, Grisha Szep, Zoya Georgieva, et al.
Nature Communications|November 5, 2023
Tissue-resident B cells orchestrate macrophage polarisation and functionOndrej Suchanek, John R Ferdinand, Zewen K Tuong, et al.
BMC Nephrology|March 28, 2026
The UK Eastern Network for Kidney Inflammatory Disease (ENKID) MDT at 24 months: advancing access to high-cost drugs, clinical trials, and complex case management in renal autoimmune diseasesLucy Francis, Olivia Kanka, Ondrej Suchanek, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
HLA|October 6, 2020
Novel strategies to target the humoral alloimmune responseOndrej Suchanek, Menna R Clatworthy
Frontiers in Immunology|September 25, 2023
Homeostatic role of B-1 cells in tissue immunityOndrej Suchanek, Menna R Clatworthy
Rheumatology (Oxford, England)|June 17, 2021
Therapeutic dilemmas in relapsing renal ANCA-associated vasculitisOndrej Suchanek, David R W Jayne, Rachel B Jones
CEN Case Reports|June 21, 2022
Use of rituximab in SARS-CoV-2-positive renal transplant recipient with EBV reactivation and probable haemophagocytic lymphohistiocytosisDerek Chan, Sabina Karimi, George Follows, et al.
Annual Review of Immunology|April 26, 2022
Tissue Immunity in the BladderGeorgina S Bowyer, Kevin W Loudon, Ondrej Suchanek, et al.
BMJ Quality Improvement Reports|January 7, 2016
Mind the gap: Improving discharge communication between secondary and primary careAynsley Cresswell, Matthew Hart, Ondrej Suchanek, et al.
Kidney International Reports|May 2, 2022
Incidence, Risk Factors and Outcomes of Kidney and Liver Cyst Infection in Kidney Transplant Recipient With ADPKDCharles Ronsin, Anis Chaba, Ondrej Suchanek, et al.
Frontiers in Immunology|August 1, 2024
FlowAtlas: an interactive tool for high-dimensional immunophenotyping analysis bridging FlowJo with computational tools in JuliaValerie Coppard, Grisha Szep, Zoya Georgieva, et al.
Nature Communications|November 5, 2023
Tissue-resident B cells orchestrate macrophage polarisation and functionOndrej Suchanek, John R Ferdinand, Zewen K Tuong, et al.
BMC Nephrology|March 28, 2026
The UK Eastern Network for Kidney Inflammatory Disease (ENKID) MDT at 24 months: advancing access to high-cost drugs, clinical trials, and complex case management in renal autoimmune diseasesLucy Francis, Olivia Kanka, Ondrej Suchanek, et al.
Pageof 2